Zhang Xiaoyang – Trademark Portfolio
Entity Type: 01
Zhang Xiaoyang owns a portfolio of 9 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), including well-known marks such as LEROW, EGPICO, YORXIE, SANTASY, and COMON HOME. Of these, 5 are registered. The portfolio spans 6 Nice Classification classes, led by Class 9 (Computers & Electronics) and Class 28 (Toys & Sporting Goods). Headquartered in Luohe.
No.246 Getazhang Vill,Dengxiang Town,
Zhaoling Dist.,
Luohe 462000 , CN
Showing of trademarks Trademarks
Trademark Classifications
Zhang Xiaoyang's trademark portfolio spans 6 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Games and playthings; gymnastic and sporting articles; decorations for Christmas trees
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Zhang Xiaoyang have?
Zhang Xiaoyang has 9 U.S. trademarks filed with the USPTO. Of these, 5 registered, 1 abandoned, 3 cancelled.
What trademark classes does Zhang Xiaoyang file in?
Zhang Xiaoyang files trademarks across 6 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 28 (Toys & Sporting Goods), Class 25 (Clothing), Class 24 (Fabrics), Class 21 (Housewares). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.
What are Zhang Xiaoyang's most well-known trademarks?
Zhang Xiaoyang's registered trademark portfolio includes well-known marks such as LEROW, EGPICO, YORXIE, SANTASY, and COMON HOME. These are among 5 currently registered trademarks in the portfolio.
What is Zhang Xiaoyang's trademark registration success rate?
Zhang Xiaoyang has a 56% trademark registration rate, with 5 out of 9 resolved applications resulting in successful registration. Currently, 0 applications are pending review.